HotSpot and Excelra partner to support HotSpot's allosteric inhibitor candidate pipeline May 26, 2022
CureVac and myNEO enter research and option agreement toward development of mRNA cancer vaccines May 26, 2022
Evusheld retains neutralization activity against SARS-CoV-2 Omicron BA.4 and BA.5 variants May 26, 2022